Evidence map›Paper›PMID 35457271›Full record

ReviewInternational journal of molecular sciences2022

CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement.

Workie Anley Zegeye, Mesfin Tsegaw, Yingxin Zhang, Liyong Cao

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Graft Biology in the CRISPR Era: From Tissue Fusion to Genome Compatibility.Plant-environment interactions (Hoboken, N.J.) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Editing theInternational journal of molecular sciences · 2025
    Article
  10. CRISPR-Based Editing of thePlants (Basel, Switzerland) · 2024
    Article
  11. Review
  12. Review
  13. Somatic Embryogenesis andPlants (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Application of CRISPR/CasΦ2 System for Genome Editing in Plants.International journal of molecular sciences · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Workie Anley ZegeyeState Key Laboratory of Rice Biology, China National Rice Research Institute, Hangzhou 310006, China.
Mesfin TsegawDepartment of Agricultural Biotechnology, Institute of Biotechnology, University of Gondar, Gondar P.O. Box 196, Ethiopia.
Yingxin ZhangState Key Laboratory of Rice Biology, China National Rice Research Institute, Hangzhou 310006, China.
Liyong CaoState Key Laboratory of Rice Biology, China National Rice Research Institute, Hangzhou 310006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To increase the potentiality of crop production for future food security, new technologies for plant breeding are required, including genome editing technology-being one of the most promising. Genome editing with the CRISPR/Cas system has attracted researchers in the last decade as a safer and easier tool for genome editing in a variety of living organisms including rice. Genome editing has transformed agriculture by reducing biotic and abiotic stresses and increasing yield. Recently, genome editing technologies have been developed quickly in order to avoid the challenges that genetically modified crops face. Developing transgenic-free edited plants without introducing foreign DNA has received regulatory approval in a number of countries. Several ongoing efforts from various countries are rapidly expanding to adopt the innovations. This review covers the mechanisms of CRISPR/Cas9, comparisons of CRISPR/Cas9 with other gene-editing technologies-including newly emerged Cas variants-and focuses on CRISPR/Cas9-targeted genes for rice crop improvement. We have further highlighted CRISPR/Cas9 vector construction model design and different bioinformatics tools for target site selection.

Indexed as

Gene EditingOryzaCRISPR-Cas SystemsCrops, AgriculturalGenome, PlantPlant BreedingPlants, Genetically ModifiedCas variantsCRISPR/Cas9genome editingimprovementsrice

Identifiers

PMID35457271
PMCPMC9027422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.